Aducanumab (BIIB037) is a human monoclonal antibody that selectively targets aggregated amyloid-beta (Abeta). Aducanumab shows blood-brain-barrier penetration, and can be used for Alzheimers disease (AD) research[1].
Molecular Weight:
(146.2 kDa)
Purity:
99.25
CAS Number:
[1384260-65-4]
Target:
Amyloid-beta
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted